Fengxian's Industrial Ecosystem Empowers Probiotics Tech to Cross-Industry Integration
On December 3rd, Fengxian District successfully hosted the 2025 Xian Shang Conference, bringing together nearly 450 entrepreneurs and chamber of commerce representatives from various industries within the district to discuss new avenues for the development of the private economy. As one of Shanghai's most vibrant regions for private enterprise, Fengxian District saw its private companies constitute nearly 90% of the total enterprises in 2024, contributing over 60% of the industrial output above designated size, more than half of tax revenue, and over 60% of employment opportunities, demonstrating robust economic vitality.
At this conference, Fengxian District recognized outstanding enterprises and innovative business cases, including the Top Ten Leading Xian Merchants, Top Ten Pioneer Xian Merchants, and Top Ten Youth Innovation Xian Merchants. Bioyitech, as a burgeoning force in Fengxian's major health industry, was also invited to participate in this grand event, joining "old friends" deeply rooted in Fengxian and "new friends" bringing cutting-edge technology to discuss innovation and share opportunities.
Fengxian's Industrial Ecosystem Facilitates Team Scaling
Li Jiadong, founder of Bioyitech and a "Xian Cheng Craftsman," stated at the conference, "We chose Fengxian precisely because of its comprehensive industrial ecosystem." In 2023, Li Jiadong led a team with 30 years of research and development accumulation to establish a presence in Fengxian, focusing on the R&D and production of functional Probiotic Strains such asBifidobacterium animalis subsp. lactis F1-7, Lactobacillus paracasei X11 .
Fengxian District has gathered well-known dairy and pharmaceutical companies like Bright Dairy, as well as supporting resources for the "Beautiful Great Health" industrial cluster, providing Bioyitech with an exceptional development environment. "Our strains require close collaboration with dairy and pharmaceutical companies. Fengxian's industrial layout has saved us significant integration costs, enabling us to quickly transition from laboratory breakthroughs to large-scale production," said Li Jiadong.
Deepening the "Probiotics+" Strategy to Build Niche Market Competitiveness
Leveraging Fengxian's locational and industrial advantages, Bioyitech plans to further deepen its cross-industry integration path with "Probiotics+". Building upon its expertise in functional probiotic research, the company will explore integration with traditional Chinese medicine and functional food sectors, aiming to establish an indispensable technological and product advantage in niche markets.
"Fengxian not only provides efficient connections within our upstream and downstream value chains but also opens broader market channels," emphasized Li Jiadong. Bioyitech will continue to rely on Fengxian's industrial cluster effect to accelerate technological transformation and drive innovation in the health food industry.
Xian Shang Conference: A Testament to the Resilience and Vitality of the Private Economy
The annual Xian Shang Conference has become a vital platform for Fengxian's private economy to showcase its vitality and share opportunities. Bioyitech's story is a microcosm of Fengxian's continuous optimization of its business environment and the construction of its industrial ecosystem. Here, both loyal partners who have been established for a long time and are continuously investing, alongside emerging forces like Bioyitech bringing innovative technologies, collectively contribute to Fengxian's innovative landscape of the private economy.
In the future, Bioyitech will continue to collaborate with Fengxian, empowering the health industry with technology, and writing more innovation stories from lab to market through its cross-industry exploration of "Probiotics+".